F-group (family)
101.1.2.88 Dimerisation
Ligands and drugs
585
Member domains
144
with ligand contacts (≤ 4 Å)
24.6% of members
113
with DrugDomain annotations
19.3% of members
60
with a DrugBank compound
10.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 101.1.2.88 belongs to X-group 101 HTH, which binds 8.7 ligand superclasses per 20 proteins, broader than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02709 | STL | Resveratrol | 4 |
| DB03199 | ERT | 4-Methoxy-E-Rhodomycin T | 4 |
| DB03345 | BME | Mercaptoethanol | 4 |
| DB19070 | 3VL | Aklavine | 4 |
| DB01880 | DHC | 3,4-Dihydroxycinnamic Acid | 2 |
| DB02282 | MTA | 5'-S-methyl-5'-thioadenosine | 2 |
| DB07352 | AGI | Apigenin | 2 |
| DB15334 | QSO | Biochanin A | 2 |
| DB17939 | 3RL | Pterostilbene | 2 |
| DB01065 | — | Melatonin | 1 |
| DB01692 | DTU | Dithioerythritol | 1 |
| DB02184 | DTV | D-1,4-dithiothreitol | 1 |
| DB03219 | DRA | 11-Deoxy-Beta-Rhodomycin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 10 |
| SLX | (13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol | 10 |
| NAmetal | SODIUM ION | 9 |
| A1LWB | 4-farnesyl-3,5-dihydroxy-6-methylphthalide | 6 |
| A1LWD | O-desmethyl mycophenolic acid | 6 |
| N7I | 4-[(1E)-3-hydroxyprop-1-en-1-yl]-2-methoxyphenol | 6 |
| UNL | Unknown ligand | 6 |
| B0L | 4-hydroxy-3-[(2S,6E,8E)-2-methyldeca-6,8-dienoyl]-5-phenylpyridin-2(1H)-one | 4 |
| BME | BETA-MERCAPTOETHANOL | 4 |
| CIY | (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal | 4 |
| SNY | (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal | 4 |
| STL | RESVERATROL | 4 |
| EMO | 3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE | 3 |
| 3RL | Pterostilbene | 2 |
| 5NA | 2-hydroxy-5-methyl naphthoic acid | 2 |
| 7NA | 2-hydroxy-7-methoxy-5-methyl naphthoic acid | 2 |
| 8KZ | 3-[(E)-2-(4-hydroxyphenyl)ethenyl]-5-methoxy-phenol | 2 |
| A1EI6 | (7S,9R,10R)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethyl-4-methoxy-6,9,10,11-tetrakis(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione | 2 |
| A1L3V | (7~{S},9~{S})-7-[(2~{R},4~{S},5~{S},6~{S})-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethyl-4-methoxy-6,9,11-tris(oxidanyl)-8,10-dihydro-7~{H}-tetracene-5,12-dione | 2 |
| B3O | (1R,2R,4aS,8S,8aR)-2,8-dimethyl-5'-phenyl-4a,5,6,7,8,8a-hexahydro-2H,2'H-spiro[naphthalene-1,3'-pyridine]-2',4'(1'H)-dione | 2 |